MIXED REALITY FOR PHARMACEUTICAL COMPANIES
Conveying medical content spatially and interactively
Mixed Reality for pharmaceutical companies combines the real environment with interactive digital 3D content. As a result, medical relationships, mechanisms of action, anatomical structures, or complex product information can be displayed directly in space and viewed from different perspectives. For pharmaceutical companies, this creates a medium that not only presents scientific content, but makes it spatially tangible.
Mixed Reality for Pharmaceutical Companies at a Glance
As Mixed-Reality Agency Design4real develops individual mixed-reality applications for pharma, healthcare, and medical communication. The focus is not on the headset as a technical effect, but on the question of which content can be better understood spatially and how an MR application can be meaningfully integrated into the workflow. Congresses, HCP meetings, trainings, internal training sessions, or product communication.
Unlike virtual reality, the real environment remains visible in mixed reality. Digital content is spatially anchored within it. An mechanism of action can, for example, appear as a three-dimensional model on a real table while participants can still see their conversation partners, the trade fair booth, or the training room. Especially in communicative situations, this can be an important advantage.
Where Mixed Reality can be used effectively in pharma and healthcare
Mixed Reality is particularly well-suited for pharmaceutical companies when it comes to content that is difficult to understand or can only be depicted abstractly in traditional presentations. This includes molecular processes, mechanisms of action, anatomical relationships, multi-step treatment pathways, or the technical functionality of medical products.
Mechanism of Action and Medical 3D Visualization
A typical application area is the spatial representation of a mode of action. Instead of showing multiple two-dimensional slides one after another, a biological or pharmacological process can be placed in space as an animated 3D model. Cell structures, receptors, drug pathways, or anatomical areas can be gradually faded in, scaled, or separated from one another.
What is important here is scientific traceability. The design may simplify medical content, but it should not create false contexts. Therefore, it makes sense to firmly integrate technical approval by Medical Affairs, scientific contacts, or other responsible departments into the production process.
Mixed reality for pharmaceutical companies is also suitable for spatial exploded views and layered models. For example, anatomical structures can be made transparent or exposed one after the other. This makes it possible to explain relationships between tissues, organs, and therapeutic principles more understandably than with static illustrations.
Medical congresses, HCP dialogues, and exhibition stands
At medical congresses, a special communication situation often arises: professional visitors have little time, while at the same time complex content needs to be conveyed precisely. An MR application can be used here as a conversation tool.
The advantage over fully immersive VR is that the real conversation situation is preserved. Users continue to see the booth, the conversation partner, and other people. At the same time, spatial 3D content can appear directly in front of them. As a result, mixed reality can be easily integrated into guided HCP conversations for pharmaceutical companies.
For a functioning congress deployment, the application should have a compact design. A clear starting position, few understandable interactions, fast session resets, and an accompanying display on an external screen are in many cases more important than a large number of features. An additional screen can also ensure that people without a headset can follow the conversation.
Training and internal communication
Mixed Reality can be used not only for external communication, but also for internal training. For example, new employees can spatially explore product relationships, medical fundamentals, or complex process chains.
Unlike a traditional e-learning application, the learning content can be embedded into a real space. As a result, real working materials, conversation situations, or physical objects can be combined with virtual information.
For comprehensive training projects, however, it should first be checked whether mixed reality is actually the appropriate medium. If a real danger must be completely eliminated or a completely virtual environment is required, VR can be the better choice. Technology-neutral planning prevents mixed reality from being used simply because it currently appears particularly prominent or new.
Technical implementation of mixed reality for pharmaceutical companies
A professional mixed reality application consists of significantly more than just a 3D model in space. Crucial factors are tracking, spatial anchoring, performance, interaction design, and the technical preparation of the medical content.
3D models, animations and medical data
Many pharmaceutical projects begin with pre-existing 3D data, illustrations, molecular models, anatomical visualizations, or existing animations. While this data can serve as an important foundation, it cannot be automatically transferred into a real-time MR application without modification.
For mobile XR hardware, geometries, materials, textures, and animations must be optimized to achieve a stable frame rate. At the same time, the medically relevant information must not be lost. Especially in scientific visualizations, this balance between technical optimization and professional precision is crucial.
Design4real typically develops such applications in real-time 3D engines like Unity or Unreal and can prepare existing assets for the respective target platform. Where appropriate, OpenXR can be used to make the architecture less tied to a single hardware manufacturer. OpenXR reduces platform dependency, but does not mean that an application will function identically on every headset without adjustments.
Spatial anchoring and interaction
For mixed reality to work convincingly for pharmaceutical companies, digital content must remain stably anchored in the real room. To achieve this, current MR headsets use cameras, depth sensors, and spatial tracking.
During a table presentation, for example, an anatomical diorama can be anchored to a real table surface. Users can move around it and view the content from different perspectives. Alternatively, virtual content can be placed on the floor, on walls, or in freely defined positions in space.
Interactions can be done via Hand tracking or controller. Hand tracking often feels especially direct in presentation situations because no additional input device needs to be explained. However, for more precise or extensive interactions, controllers can be more robust. The decision should therefore be derived from the specific scenario.
Current enterprise hardware such as the PICO 4 Ultra Enterprise combines 6DoF tracking, two 32-megapixel color cameras for passthrough, and an iToF depth-sensing camera. For enterprise rollouts, business and device management features are also available. Since XR hardware develops rapidly, we will re-examine the specific device selection at the start of the project.
Operations, data protection, and rollout
In pharmaceutical projects, it is not just the application itself that plays a role. Device operation, network access, user data, and organizational processes must also be considered early on.
Many applications can be designed to run entirely locally on the headset. This can be useful if no stable internet connection is available at conferences or if as little data as possible is to be processed. If backend functions, analytics, user profiles, or cloud services are integrated, data flows must be planned transparently and evaluated under data protection laws.
During larger rollouts, mobile device management features can help distribute apps, configure devices, and update content centrally. For trade fair or conference deployments, a kiosk mode, automatic startup, defined session reset, and a clear charging and hygiene workflow are also added.
Medical communication, regulatory affairs and scientific validation
Mixed reality for pharmaceutical companies can be used for communication, training, and visualization. However, it does not automatically follow that such an application is a medical device.
In the EU, regulatory classification depends largely on the intended purpose. The Medical Device Regulation defines a medical product, among other things, by the medical purpose intended by the manufacturer. Software can also fall under this category if, for example, it is intended for diagnosis, monitoring, prediction, or treatment.
An MR application that visualizes a mechanism of action or conveys medical information at a congress is therefore to be evaluated differently from a regulatory perspective than software intended to support diagnostic or therapeutic decisions. The specific classification must be carried out on a project-specific basis and should be coordinated with the responsible regulatory and legal teams.
The current FDA overview of AR/VR medical devices also shows that immersive technologies are now used in numerous regulated clinical applications. At the same time, the FDA clearly distinguishes between general AR/VR technology and specific medical devices with a defined intended use.
From the idea to the mixed reality application
A mixed reality project for pharmaceutical companies should not start with the question of which headset is used. At the beginning are the target group, communication goal, and content.
Design4real therefore typically starts with a content and technical conceptual phase. We clarify which message is to be communicated, who will use the application, in what environment it will be used, and how long a typical session should last.
Subsequently, a storyboard, interaction concept, and initial prototype are created. Especially with medical content, an early prototype is helpful because spatial proportions, legibility, motion sequences, and interactions can only be evaluated to a limited extent on a 2D storyboard.
This is followed by 3D production or asset preparation, real-time integration, animation, interaction development, sound, and, if applicable, backend or device management integration. Medical content is coordinated in parallel with the relevant departments.
Before the rollout, the application is tested on the actual target hardware. At trade fairs, the actual booth operations should also be simulated: lighting, spatial conditions, visitor frequency, hygiene, assistance, and switching between multiple users can significantly influence the user experience.
Design4real has more than ten years of experience in VR, AR, and interactive real-time 3D applications. For Pharmaand Healthcare-projects we combine this technical experience with a workflow-oriented approach to scientific visualization, training, and medical communication.
Find more on the parent service area under:
Do you want to convey medical content spatially and interactively using mixed reality? Design4real develops customized MR applications for pharma, healthcare, medical affairs, congresses, and internal training. Talk to us about your specific use case – together we will evaluate whether mixed reality, VR, AR, or another interactive 3D solution is the most sensible implementation.
Matching services: Virtual Reality for Pharma & Medicine
Further sources: EU Medical Device Regulation, Regulation (EU) 2017/745 · FDA – Augmented Reality and Virtual Reality in Medical Devices · Khronos OpenXR Registry
Frequently Asked Questions about Mixed Reality for Pharmaceutical Companies
Mixed Reality connects the real environment with spatially anchored digital 3D content. For example, pharmaceutical companies can use it to visualize mechanisms of action, anatomical models, product information, or medical processes in real space and explain them interactively.
Yes. Especially three-dimensional biological or anatomical processes can be spatially represented, animated, and explained step by step in MR. Crucial factors are scientifically accurate preparation and a defined medical approval process.
No. The regulatory classification depends on the specific intended purpose. An application for communication or training may be classified differently than software with a diagnostic or therapeutic function. Regulatory and Legal should therefore be involved on a project-specific basis.
That depends on the application. For conferences, training sessions, and enterprise rollouts, current standalone MR headsets with color passthrough, 6DoF tracking, and device management features are options. The hardware selection should be reviewed at the start of each project.
Often yes. However, existing 3D models, CAD data, or animations usually need to be optimized for real-time rendering and mobile XR hardware. In the process, the scientifically relevant level of detail should be preserved.
If the application is modular, optimized 3D assets and animations can often also be used for VR, AR, touchscreens, real-time 3D presentations, or web applications. This should already be taken into account during the architecture phase.
Let's talk about your project.
Whether Virtual Reality, Augmented Reality, or WebAR: We provide tailored advice and develop immersive applications that fit your brand and target audience. Free initial consultation, personal and at eye level.
+49 179 3927971 · info@design4real.de · Lindwurm St. 95a, Munich